Medika d.d. Logo

Medika d.d.

ISIN: HRMDKARA0000 | Ticker: MDKA | LEI: 74780000O0R8ZVGJJO27
Sector: Health CareSub-Industry: Pharmaceuticals
Country: Croatia

About Medika d.d.

Company Description

Medika supplies pharmacies, healthcare facilities, hospitals, community health centres, outpatient clinics, medical practices, pharmaceutical wholesalers and specialized shops with the widest range of products of all pharmaceutical wholesalers. Drawing on the tradition and an innovative approach to day-to-day business operations, Medika sets new standards in the quality of service which has helped it retain the market leader position for over five decades.

Way back since 1922, Medika has been developing and making progress at the highest level of quality, value and innovation in the pharmaceutical industry. We know that knowledge acquired through continuous education is more effective if complemented by experience gained through years of work. Proud of our tradition, we are ready to continuously innovate and improve quality. Due to experience and new knowledge, Medika nowadays faces a successful future.

Year founded


Served area



Capraška 1, 10000 Zagreb – Croatia

Financial statements

Download as Excel
Line item in (hrk) 02.01.2020 01.01.2021 02.01.2021 01.01.2022
Assets N/A 2,592,463,000.00 N/A 2,329,076,000.00
Noncurrent Assets N/A 491,142,000.00 N/A 546,803,000.00
Property Plant And Equipment N/A 181,714,000.00 N/A 232,588,000.00
Investments In Subsidiaries N/A 24,195,000.00 N/A 25,856,000.00
Noncurrent Receivables N/A 11,822,000.00 N/A 5,371,000.00
Deferred Tax Assets N/A 746,000.00 N/A 999,000.00
Current Assets N/A 2,101,321,000.00 N/A 1,782,273,000.00
Inventories N/A 373,563,000.00 N/A 356,486,000.00
Trade And Other Current Receivables N/A 1,649,226,000.00 N/A 1,340,680,000.00
Cash and cash equivalents 53,421,000.00 78,468,000.00 78,468,000.00 85,107,000.00
Equity And Liabilities N/A 2,592,463,000.00 N/A 2,329,076,000.00
Equity 504,628,000.00 545,527,000.00 545,527,000.00 638,928,000.00
Issued Capital N/A 164,399,000.00 N/A 191,429,000.00
Retained Earnings N/A 313,768,000.00 N/A 380,139,000.00
Other Reserves N/A 67,360,000.00 N/A 67,360,000.00
Noncurrent Liabilities N/A 61,537,000.00 N/A 121,164,000.00
Noncurrent Provisions N/A 1,334,000.00 N/A 1,414,000.00
Noncurrent Payables N/A N/A N/A 28,438,000.00
Deferred Tax Liabilities N/A 17,696,000.00 N/A 19,350,000.00
Noncurrent Portion Of Noncurrent Loans Received N/A N/A N/A 34,378,000.00
Current Liabilities N/A 1,985,399,000.00 N/A 1,568,984,000.00
Current Provisions N/A 1,198,000.00 N/A 342,000.00
Trade And Other Current Payables To Trade Suppliers N/A 1,666,705,000.00 N/A 1,526,346,000.00
Current Tax Liabilities Current N/A 10,475,000.00 N/A 11,459,000.00
Line item in (hrk) 01.01.2020/
Revenue 3,989,597,000.00 4,130,394,000.00
Advertising Expense -5,063,000.00 -8,274,000.00
Employee Benefits Expense -133,025,000.00 -142,633,000.00
Depreciation And Amortisation Expense -26,795,000.00 -29,218,000.00
Other Expense By Nature -47,306,000.00 -51,859,000.00
Other Gains Losses -8,660,000.00 1,487,000.00
Profit Loss From Operating Activities 97,251,000.00 111,883,000.00
Finance Income 1,728,000.00 10,593,000.00
Finance Costs -7,515,000.00 -4,457,000.00
Profit Loss Before Tax 93,762,000.00 120,856,000.00
Income Tax Expense Continuing Operations -16,888,000.00 -21,347,000.00
Profit (loss) 76,874,000.00 99,509,000.00
Line item in (hrk) 01.01.2021 02.01.2020 01.01.2022 02.01.2021
Profit (loss) 76,874,000.00 N/A 99,509,000.00 N/A
Adjustments For Income Tax Expense 16,888,000.00 N/A 21,347,000.00 N/A
Adjustments For Decrease Increase In Inventories 4,888,000.00 N/A 9,789,000.00 N/A
Adjustments For Depreciation And Amortisation Expense 26,795,000.00 N/A 29,218,000.00 N/A
Adjustments For Provisions -6,000.00 N/A -776,000.00 N/A
Adjustments For Unrealised Foreign Exchange Losses Gains -2,303,000.00 N/A 1,590,000.00 N/A
Adjustments For Sharebased Payments N/A N/A 5,018,000.00 N/A
Other Adjustments For Noncash Items -9,000.00 N/A 13,000.00 N/A
Adjustments For Losses Gains On Disposal Of Noncurrent Assets 7,000.00 N/A N/A N/A
Cash Flows From Used In Operations 124,853,000.00 N/A 358,788,000.00 N/A
Interest Paid Classified As Operating Activities -7,310,000.00 N/A -4,750,000.00 N/A
Income Taxes Paid Refund Classified As Operating Activities -9,149,000.00 N/A -20,643,000.00 N/A
Cash Flows From Used In Operating Activities 108,394,000.00 N/A 333,395,000.00 N/A
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities 901,000.00 N/A 2,711,000.00 N/A
Purchase Of Property Plant And Equipment Classified As Investing Activities -10,059,000.00 N/A -63,747,000.00 N/A
Proceeds From Sales Of Intangible Assets Classified As Investing Activities -2,528,000.00 N/A -10,550,000.00 N/A
Purchase Of Intangible Assets Classified As Investing Activities -7,356,000.00 N/A -7,090,000.00 N/A
Proceeds From Government Grants Classified As Investing Activities N/A N/A 1,011,000.00 N/A
Cash Advances And Loans Made To Other Parties Classified As Investing Activities -2,250,000.00 N/A N/A N/A
Cash Receipts From Repayment Of Advances And Loans Made To Other Parties Classified As Investing Activities 8,671,000.00 N/A 7,430,000.00 N/A
Interest Received Classified As Investing Activities 1,719,000.00 N/A 10,467,000.00 N/A
Other Inflows Outflows Of Cash Classified As Investing Activities 131,000.00 N/A -46,000.00 N/A
Cash Flows From Used In Investing Activities -10,624,000.00 N/A -58,638,000.00 N/A
Proceeds From Borrowings Classified As Financing Activities 885,000,000.00 N/A 487,000,000.00 N/A
Repayments Of Borrowings Classified As Financing Activities -907,008,000.00 N/A -728,760,000.00 N/A
Payments Of Lease Liabilities Classified As Financing Activities -14,740,000.00 N/A -15,232,000.00 N/A
Dividends Paid Classified As Financing Activities -35,975,000.00 N/A -38,156,000.00 N/A
Cash Flows From Used In Financing Activities -72,723,000.00 N/A -268,118,000.00 N/A
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes 25,047,000.00 N/A 6,639,000.00 N/A
Cash and cash equivalents 78,468,000.00 53,421,000.00 85,107,000.00 78,468,000.00

Please note that some sums might not add up.

Filings & Publications


Consolidated Report
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Sign up and we will give you access!

Capital markets information






Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences





Listed Stock Exchange

Zagreb Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.